Skip to main content

QUESTION: I have a patient with prostate cancer and a rising PSA after prostatectomy. He’s coming off a lupron shot, which is when the PSA started increasing. I treated him with basic naturopathic care with attention to the cancer, including 50 g AA twice weekly for a month. He has now had a massive heart attack and coded several times. They used the paddles on him and bashed his ribs and sternum pretty badly. Placed two stents for 100% and 90% occlusions. I don’t need to treat this guy intravenously. He would have continued for a couple of months with IV therapies if he hadn’t had the MI. However, if it’s recommended or not recommenced is the question I’m most interested to know? I’m mostly focused on preventing re-stenosis. Which I’ve done on the oral and lifestyle front. He’s beat up pretty bad, so healing is important. I don’t want to use phosphatidylcholine with his prostate cancer. He’s on plavix and refused the 325 aspirin. Had a bad bleeding episode with aspirin in the past. If you don’t think there are any major contraindications. Do you think some kind of IV therapies would be beneficial?

ANSWER: Aside from monitoring the CV parameters pre and post IV I usually see the MI folks do OK with IV stuff. Given the limitations of what we can infuse, we normally look at supporting redox and repair as possible ‘while’ keeping the major electrolytes stable. This looks like a base of the typical B-Vitamins with added B1&2 for mitochondrial support, cl-salts of Mg/K and Ca, Trace elements as required (usually do an RBC element panel) at least taurine and carnitine (we add Aminosyn to the bag as well). Then we end with glutathione. If desired and tolerated we’ll recommend PTC IV as well, basically feeding the Mitochondria, not rocking the cardioactive mineral boat.

Dr. Paul Anderson

Paul S. Anderson is a naturopathic physician, Medical Director & Founder of Anderson Medical Specialty Associates (AMSA). He is a recognized authority in the field of integrative cancer research and the treatment of chronic diseases, genomic conditions, and auto-immune and infectious disorders.